Detalle Publicación

ARTÍCULO
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations
Autores: Caliz, R. C. (Autor de correspondencia); Fontecha, P. D. D. ; Izquierdo, M. G. ; Longo, F. J. L.; Zamora, M. A. M. ; Ortiz, A. S.; Pliego, O. A. ; Cuadrado Lozano, María José; Beltran, M. P. D.; Ortells, L. C.; Perez, E. C. C. ; Rego, G. D. C. ; Corral, S. G.; Varela, C. F.; Lopez, M. M.; Nishishinya, B.; Navarro, M. N. ; Testa, C. P.; Perez, H. S. ; Silva-Fernandez, L. ; Taboada, V. M. M.
Título de la revista: REUMATOLOGIA CLINICA
ISSN: 1699-258X
Volumen: 16
Número: 2
Páginas: 133 - 148
Fecha de publicación: 2020
Lugar: WOS
Resumen:
Objective: The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. Methods: A panel of 4 rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for the document elaboration, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network, SIGN levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). Results: Forty-six recommendations were drawn up, addressing 5 main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the last 25, referring to the areas of: obstetric APS and special situations. The document provides a table of recommendations and treatment algorithms. Conclusions: Update of SER recommendations on APS is presented. This document corresponds to part II, related to obstetric SAF and special situations. These recommendations are considered tools for decisionmaking for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A part I has also been prepared, which addresses aspects related to diagnosis, evaluation and treatment. Published by Elsevier Espalia, S.L.U.